02.06.2018
Improve Outcomes
$3,016,000.00
24 months
Early Feasibility Studies of the Glucowizzard in Care for T1D
Funding to support the first human trial of Biorasis' implantable glucose biosensor, Glucowizzard™, and allow the device development to move forward with future clinical trials.